roy castle lung cancer foundation
roy castle lung cancer foundation Company Information
Group Structure
View All
Industry
Other human health activities
Registered Address
cotton exchange old hall street, liverpool, L3 9LQ
Website
www.roycastle.orgroy castle lung cancer foundation Estimated Valuation
Pomanda estimates the enterprise value of ROY CASTLE LUNG CANCER FOUNDATION at £2.7m based on a Turnover of £5m and 0.54x industry multiple (adjusted for size and gross margin).
roy castle lung cancer foundation Estimated Valuation
Pomanda estimates the enterprise value of ROY CASTLE LUNG CANCER FOUNDATION at £0 based on an EBITDA of £-596.1k and a 4.19x industry multiple (adjusted for size and gross margin).
roy castle lung cancer foundation Estimated Valuation
Pomanda estimates the enterprise value of ROY CASTLE LUNG CANCER FOUNDATION at £1.4m based on Net Assets of £608.7k and 2.35x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Roy Castle Lung Cancer Foundation Overview
Roy Castle Lung Cancer Foundation is a live company located in liverpool, L3 9LQ with a Companies House number of 03059425. It operates in the other human health activities sector, SIC Code 86900. Founded in May 1995, it's largest shareholder is unknown. Roy Castle Lung Cancer Foundation is a mature, small sized company, Pomanda has estimated its turnover at £5m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Roy Castle Lung Cancer Foundation Health Check
Pomanda's financial health check has awarded Roy Castle Lung Cancer Foundation a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 4 areas for improvement. Company Health Check FAQs
6 Strong
2 Regular
4 Weak
Size
annual sales of £5m, make it larger than the average company (£798.1k)
£5m - Roy Castle Lung Cancer Foundation
£798.1k - Industry AVG
Growth
3 year (CAGR) sales growth of 8%, show it is growing at a similar rate (6.5%)
8% - Roy Castle Lung Cancer Foundation
6.5% - Industry AVG
Production
with a gross margin of 36.5%, this company has a comparable cost of product (36.5%)
36.5% - Roy Castle Lung Cancer Foundation
36.5% - Industry AVG
Profitability
an operating margin of -12.8% make it less profitable than the average company (5.6%)
-12.8% - Roy Castle Lung Cancer Foundation
5.6% - Industry AVG
Employees
with 158 employees, this is above the industry average (19)
158 - Roy Castle Lung Cancer Foundation
19 - Industry AVG
Pay Structure
on an average salary of £19.6k, the company has a lower pay structure (£27k)
£19.6k - Roy Castle Lung Cancer Foundation
£27k - Industry AVG
Efficiency
resulting in sales per employee of £31.5k, this is less efficient (£51.5k)
£31.5k - Roy Castle Lung Cancer Foundation
£51.5k - Industry AVG
Debtor Days
it gets paid by customers after 6 days, this is earlier than average (22 days)
6 days - Roy Castle Lung Cancer Foundation
22 days - Industry AVG
Creditor Days
its suppliers are paid after 55 days, this is slower than average (17 days)
55 days - Roy Castle Lung Cancer Foundation
17 days - Industry AVG
Stock Days
it holds stock equivalent to 12 days, this is less than average (16 days)
12 days - Roy Castle Lung Cancer Foundation
16 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 2 weeks, this is less cash available to meet short term requirements (101 weeks)
2 weeks - Roy Castle Lung Cancer Foundation
101 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 65.5%, this is a higher level of debt than the average (27.9%)
65.5% - Roy Castle Lung Cancer Foundation
27.9% - Industry AVG
ROY CASTLE LUNG CANCER FOUNDATION financials
Roy Castle Lung Cancer Foundation's latest turnover from December 2023 is £5 million and the company has net assets of £608.7 thousand. According to their latest financial statements, Roy Castle Lung Cancer Foundation has 158 employees and maintains cash reserves of £39.9 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 4,971,709 | 5,306,066 | 4,686,703 | 3,970,586 | 4,805,338 | 4,514,697 | 4,505,127 | 4,795,618 | 5,643,993 | 5,381,988 | 4,679,833 | 4,953,840 | 5,227,741 | 4,710,682 | 4,769,401 |
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | |||||||||||||||
| Admin Expenses | |||||||||||||||
| Operating Profit | |||||||||||||||
| Interest Payable | 711 | 1,432 | 1,484 | 4,096 | 2,720 | 2,736 | 454 | ||||||||
| Interest Receivable | |||||||||||||||
| Pre-Tax Profit | -644,451 | -80,345 | 195,263 | -58,104 | 105,830 | -390,762 | -699,127 | -543,741 | 497,710 | 563,254 | -750,985 | -43,487 | 354,140 | 116,654 | -40,415 |
| Tax | |||||||||||||||
| Profit After Tax | -644,451 | -80,345 | 195,263 | -58,104 | 105,830 | -390,762 | -699,127 | -543,741 | 497,710 | 563,254 | -750,985 | -43,487 | 354,140 | 116,654 | -40,415 |
| Dividends Paid | |||||||||||||||
| Retained Profit | -644,451 | -80,345 | 195,263 | -58,104 | 105,830 | -390,762 | -699,127 | -543,741 | 497,710 | 563,254 | -750,985 | -43,487 | 354,140 | 116,654 | -40,415 |
| Employee Costs | 3,100,416 | 2,779,467 | 2,283,434 | 2,131,537 | 2,236,288 | 2,117,975 | 2,220,790 | 2,864,565 | 2,437,045 | 2,002,320 | 2,493,654 | 2,425,026 | 2,246,344 | 2,233,624 | 2,249,124 |
| Number Of Employees | 158 | 154 | 133 | 138 | 138 | 132 | 134 | 143 | 140 | 116 | 125 | 121 | 108 | 113 | 116 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 101,070 | 113,407 | 152,337 | 145,665 | 188,881 | 158,475 | 188,991 | 237,434 | 349,970 | 325,983 | 300,145 | 331,092 | 362,165 | 406,419 | 457,757 |
| Intangible Assets | |||||||||||||||
| Investments & Other | 669,783 | 873,367 | 1,091,892 | 1,049,672 | 1,166,512 | 1,021,338 | 1,380,714 | 1,259,051 | 1,068,497 | 1,078,087 | 924,939 | 797,446 | 742,764 | 760,071 | 533,003 |
| Debtors (Due After 1 year) | |||||||||||||||
| Total Fixed Assets | 770,853 | 986,774 | 1,244,229 | 1,195,337 | 1,355,393 | 1,179,813 | 1,569,705 | 1,496,485 | 1,418,467 | 1,404,070 | 1,225,084 | 1,128,538 | 1,104,929 | 1,166,490 | 990,760 |
| Stock & work in progress | 106,614 | 86,998 | 73,931 | 82,906 | 92,293 | 80,209 | 89,977 | 78,785 | 97,506 | 89,382 | 99,187 | 90,115 | 62,146 | 55,519 | 58,210 |
| Trade Debtors | 85,102 | 109,494 | 161,788 | 93,423 | 78,997 | 51,813 | 99,936 | 81,725 | 153,574 | 68,900 | |||||
| Group Debtors | |||||||||||||||
| Misc Debtors | 761,227 | 1,042,463 | 872,443 | 316,070 | 392,047 | 351,122 | 468,823 | 438,449 | 336,523 | 1,131,335 | 333,109 | 416,248 | 428,423 | 336,083 | 482,260 |
| Cash | 39,857 | 211,347 | 242,863 | 668,586 | 387,694 | 552,820 | 601,503 | 1,267,195 | 1,866,271 | 518,577 | 891,924 | 1,402,345 | 1,558,774 | 1,293,737 | 1,278,787 |
| misc current assets | 78,161 | 75,111 | |||||||||||||
| total current assets | 992,800 | 1,450,302 | 1,351,025 | 1,160,985 | 951,031 | 1,035,964 | 1,260,239 | 1,866,154 | 2,532,035 | 1,883,305 | 1,324,220 | 1,908,708 | 2,049,343 | 1,685,339 | 1,819,257 |
| total assets | 1,763,653 | 2,437,076 | 2,595,254 | 2,356,322 | 2,306,424 | 2,215,777 | 2,829,944 | 3,362,639 | 3,950,502 | 3,287,375 | 2,549,304 | 3,037,246 | 3,154,272 | 2,851,829 | 2,810,017 |
| Bank overdraft | |||||||||||||||
| Bank loan | 40,000 | 40,000 | 40,000 | 10,000 | |||||||||||
| Trade Creditors | 477,390 | 140,410 | 306,916 | 113,148 | 192,526 | 168,661 | 152,957 | 193,148 | 156,178 | 159,807 | |||||
| Group/Directors Accounts | 266,901 | 213,038 | 457,848 | ||||||||||||
| other short term finances | |||||||||||||||
| hp & lease commitments | 9,828 | 9,828 | 9,828 | 9,764 | |||||||||||
| other current liabilities | 445,786 | 715,173 | 605,266 | 904,919 | 917,539 | 956,587 | 1,138,951 | 1,015,391 | 1,082,760 | 886,511 | 1,020,587 | 852,733 | 678,132 | 720,546 | 646,980 |
| total current liabilities | 963,176 | 895,583 | 952,182 | 1,028,067 | 1,110,065 | 1,125,248 | 1,291,908 | 1,208,539 | 1,238,938 | 1,046,318 | 1,030,415 | 862,561 | 954,861 | 943,348 | 1,104,828 |
| loans | 73,333 | 113,333 | 153,333 | 190,000 | |||||||||||
| hp & lease commitments | 29,298 | 43,251 | 7,032 | 16,895 | 26,759 | 36,822 | |||||||||
| Accruals and Deferred Income | 4,323 | 9,507 | 14,691 | ||||||||||||
| other liabilities | |||||||||||||||
| provisions | 118,422 | 174,987 | 156,221 | 1,029 | 2,491 | ||||||||||
| total long term liabilities | 191,755 | 288,320 | 309,554 | 190,000 | 29,298 | 43,251 | 7,032 | 16,895 | 31,082 | 47,358 | 17,182 | ||||
| total liabilities | 1,154,931 | 1,183,903 | 1,261,736 | 1,218,067 | 1,110,065 | 1,125,248 | 1,291,908 | 1,208,539 | 1,268,236 | 1,089,569 | 1,037,447 | 879,456 | 985,943 | 990,706 | 1,122,010 |
| net assets | 608,722 | 1,253,173 | 1,333,518 | 1,138,255 | 1,196,359 | 1,090,529 | 1,538,036 | 2,154,100 | 2,682,266 | 2,197,806 | 1,511,857 | 2,157,790 | 2,168,329 | 1,861,123 | 1,688,007 |
| total shareholders funds | 608,722 | 1,253,173 | 1,333,518 | 1,138,255 | 1,196,359 | 1,090,529 | 1,538,036 | 2,154,100 | 2,682,266 | 2,197,806 | 1,511,857 | 2,157,790 | 2,168,329 | 1,861,123 | 1,688,007 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | |||||||||||||||
| Depreciation | 39,935 | 56,257 | 47,392 | 58,323 | 66,083 | 75,262 | 82,199 | 100,649 | 78,150 | 75,274 | 97,075 | 89,218 | 109,467 | 109,915 | 117,954 |
| Amortisation | |||||||||||||||
| Tax | |||||||||||||||
| Stock | 19,616 | 13,067 | -8,975 | -9,387 | 12,084 | -9,768 | 11,192 | -18,721 | 8,124 | -9,805 | 9,072 | 27,969 | 6,627 | -2,691 | 58,210 |
| Debtors | -305,628 | 117,726 | 624,738 | -61,551 | 68,109 | -165,824 | 48,585 | 30,077 | -710,138 | 867,126 | -83,139 | -12,175 | 92,340 | -146,177 | 482,260 |
| Creditors | 336,980 | -166,506 | 193,768 | -79,378 | 23,865 | 15,704 | -40,191 | 36,970 | -3,629 | 159,807 | |||||
| Accruals and Deferred Income | -269,387 | 109,907 | -299,653 | -12,620 | -39,048 | -182,364 | 123,560 | -67,369 | 196,249 | -134,076 | 167,854 | 170,278 | -47,598 | 68,382 | 661,671 |
| Deferred Taxes & Provisions | -56,565 | 18,766 | 156,221 | -1,029 | -1,462 | 2,491 | |||||||||
| Cash flow from operations | |||||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | 257,886 | 55,548 | -94,249 | 78,678 | 35,148 | -97,580 | -79,879 | -97,932 | -228,704 | 77,952 | |||||
| Change in Investments | -203,584 | -218,525 | 42,220 | -116,840 | 145,174 | -359,376 | 121,663 | 190,554 | -9,590 | 153,148 | 127,493 | 54,682 | -17,307 | 227,068 | 533,003 |
| cash flow from investments | 203,584 | 218,525 | -42,220 | 116,840 | -145,174 | 617,262 | -66,115 | -284,803 | 88,268 | -118,000 | -225,073 | -134,561 | -80,625 | -455,772 | -455,051 |
| Financing Activities | |||||||||||||||
| Bank loans | 30,000 | 10,000 | |||||||||||||
| Group/Directors Accounts | -266,901 | 53,863 | -244,810 | 457,848 | |||||||||||
| Other Short Term Loans | |||||||||||||||
| Long term loans | -40,000 | -40,000 | -36,667 | 190,000 | |||||||||||
| Hire Purchase and Lease Commitments | -29,298 | -13,953 | 26,391 | -9,863 | -9,864 | -9,999 | 46,586 | ||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | -711 | -1,432 | -1,484 | -4,096 | -2,720 | -2,736 | -454 | ||||||||
| cash flow from financing | -40,000 | -40,000 | -6,667 | 200,000 | -57,456 | 81,631 | -15,207 | -31,299 | 149,086 | 95,189 | -246,537 | -5,806 | -142,216 | 2,186,270 | |
| cash and cash equivalents | |||||||||||||||
| cash | -171,490 | -31,516 | -425,723 | 280,892 | -165,126 | -48,683 | -665,692 | -599,076 | 1,347,694 | -373,347 | -510,421 | -156,429 | 265,037 | 14,950 | 1,278,787 |
| overdraft | |||||||||||||||
| change in cash | -171,490 | -31,516 | -425,723 | 280,892 | -165,126 | -48,683 | -665,692 | -599,076 | 1,347,694 | -373,347 | -510,421 | -156,429 | 265,037 | 14,950 | 1,278,787 |
roy castle lung cancer foundation Credit Report and Business Information
Roy Castle Lung Cancer Foundation Competitor Analysis
Perform a competitor analysis for roy castle lung cancer foundation by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in L 3 area or any other competitors across 12 key performance metrics.
roy castle lung cancer foundation Ownership
ROY CASTLE LUNG CANCER FOUNDATION group structure
Roy Castle Lung Cancer Foundation has 3 subsidiary companies.
Ultimate parent company
ROY CASTLE LUNG CANCER FOUNDATION
03059425
3 subsidiaries
roy castle lung cancer foundation directors
Roy Castle Lung Cancer Foundation currently has 12 directors. The longest serving directors include Mr James Couton (Aug 2001) and Mr Euan Imrie (Jul 2010).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr James Couton | England | 78 years | Aug 2001 | - | Director |
| Mr Euan Imrie | 67 years | Jul 2010 | - | Director | |
| Mr Max Steinberg | England | 73 years | Dec 2015 | - | Director |
| Ms Alison Lobb | England | 55 years | Feb 2016 | - | Director |
| Mrs Alyson Chadwick | England | 52 years | Oct 2018 | - | Director |
| Mr Alastair MacHray | England | 63 years | Apr 2019 | - | Director |
| Mrs Mandee Lucas | England | 57 years | Apr 2019 | - | Director |
| Mrs Cathrine Brokenshire | England | 54 years | May 2022 | - | Director |
| Dr Emma O'Dowd | England | 42 years | Feb 2024 | - | Director |
| Mrs Jane Mullin | England | 59 years | Aug 2024 | - | Director |
P&L
December 2023turnover
5m
-6%
operating profit
-636k
0%
gross margin
36.6%
+1.02%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
608.7k
-0.51%
total assets
1.8m
-0.28%
cash
39.9k
-0.81%
net assets
Total assets minus all liabilities
roy castle lung cancer foundation company details
company number
03059425
Type
Private Limited by guarantee without Share Capital Exempt from using Limited
industry
86900 - Other human health activities
incorporation date
May 1995
age
30
incorporated
UK
ultimate parent company
accounts
Group
last accounts submitted
December 2023
previous names
the roy castle lung cancer foundation (October 2012)
the roy castle cause for hope foundation (the lung cancer fund) (May 1997)
accountant
-
auditor
RSM UK AUDIT LLP
address
cotton exchange old hall street, liverpool, L3 9LQ
Bank
BARCLAYS BANK PLC
Legal Advisor
BRABNERS CHAFFE STREET JACKSON LEES
roy castle lung cancer foundation Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to roy castle lung cancer foundation. Currently there are 1 open charges and 0 have been satisfied in the past.
roy castle lung cancer foundation Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ROY CASTLE LUNG CANCER FOUNDATION. This can take several minutes, an email will notify you when this has completed.
roy castle lung cancer foundation Companies House Filings - See Documents
| date | description | view/download |
|---|
